In a recent review published in Cell, a group of authors delved into the complexities of menopause, assessed its global impacts on health, and evaluated the effectiveness and safety of current treatments, emphasizing the importance of further research.
Alvotech resubmits its interchangeable Humira biosimilar as AbbVie clings to brand dominance
Billionaire Alvotech CEO Róbert Wessman told investors on Thursday that the company has resubmitted its Humira interchangeable biosimilar application to the FDA after receiving a